Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Total return indices include income from dividends, offering a fuller performance picture. Use them to analyze long-term trends and benchmark returns.
22,064 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Eli Lilly has enjoyed rapid growth from GLP-1 drugs, but sky-high expectations invite questions about valuations. Thi...
D-Wave Quantum stock is rallying on recent funding news and government support. This guide breaks down what that mean...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...
Kansas faces a pivotal choice on property tax reform. This article outlines why neutrality matters, how distortions c...
Investing in cosmetics often blends branding bias with numbers. This guide looks at whether e.l.f. beauty stock rhode...
Qualcomm just outlined a much larger growth plan, signaling a strong bet on AI beyond smartphones. This deep dive exp...
Palo Alto Networks has accelerated into platform play by acquiring three firms over the past year. This article break...
A billionaire shifted away from cloud giants to AI infrastructure plays. This article explains what drove the move an...
SpaceX captured attention with its IPO buzz, but jumping in right away can backfire. This guide explains why waiting ...
As Herbalife wraps up 2025, investors seek clarity on growth, margins, and the path ahead. This article breaks down w...
Is Micron stock a smart move when it trades under $500? This guide breaks down the AI memory market, Micron's role, a...